blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0687300

EP0687300 - LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.07.2002
Database last updated on 29.10.2024
Most recent event   Tooltip19.07.2002No opposition filed within time limitpublished on 04.09.2002  [2002/36]
Applicant(s)For all designated states
UNIVERSITE CATHOLIQUE DE LOUVAIN
1, Place de l'Université
1348 Louvain la Neuve / BE
[2001/37]
Former [1995/51]For all designated states
UNIVERSITE CATHOLIQUE DE LOUVAIN
2, Place de l'Université, 1
B-1348 Louvain la Neuve / BE
Inventor(s)01 / BAZIN, Hervé
120, avenue Marie-José
B-1200 Brussels / BE
02 / LATINNE, Dominique
Avenue Général-De-Longueville 16, Boîte postale 17
B-1150 Brussels / BE
[1995/51]
Representative(s)Louis Pöhlau Lohrentz
Patentanwälte
Postfach 30 55
90014 Nürnberg / DE
[N/P]
Former [1995/51]LOUIS, PÖHLAU, LOHRENTZ & SEGETH
Postfach 3055
D-90014 Nürnberg / DE
Application number, filing date94909270.404.03.1994
[1995/51]
WO1994IB00043
Priority number, dateUS1993002700805.03.1993         Original published format: US 27008
US1993011903209.09.1993         Original published format: US 119032
[1995/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9420619
Date:15.09.1994
Language:EN
[1994/21]
Type: A1 Application with search report 
No.:EP0687300
Date:20.12.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 15.09.1994 takes the place of the publication of the European patent application.
[1995/51]
Type: B1 Patent specification 
No.:EP0687300
Date:12.09.2001
Language:EN
[2001/37]
Search report(s)International search report - published on:EP15.09.1994
ClassificationIPC:C12N15/13, C12P21/08, C07K16/28, // A61K39/395
[2000/51]
CPC:
C07K16/2806 (EP); A61P37/06 (EP); A61K38/00 (EP);
C07K2317/24 (EP); C07K2319/02 (EP)
Former IPC [1995/51]C12N15/13, C12P21/08, // A61K39/395
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1995/51]
TitleGerman:LO-CD2A ANTIKÖRPER UND DESSEN VERWENDUNG ZUR INHIBITION VON T-ZELL-AKTIVIERUNG UND -WACHSTUM[1995/51]
English:LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION[1995/51]
French:ANTICORPS LO-CD2a ET SES UTILISATIONS DANS L'INHIBITION DE L'ACTIVATION ET DE LA PROLIFERATION DES LYMPHOCYTES T[1995/51]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase24.08.1995National basic fee paid 
24.08.1995Designation fee(s) paid 
24.08.1995Examination fee paid 
Examination procedure09.06.1994Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.08.1995Examination requested  [1995/51]
25.04.1997Despatch of a communication from the examining division (Time limit: M06)
30.10.1997Reply to a communication from the examining division
29.05.1998Despatch of a communication from the examining division (Time limit: M06)
04.12.1998Reply to a communication from the examining division
19.03.1999Despatch of a communication from the examining division (Time limit: M04)
26.07.1999Reply to a communication from the examining division
29.11.1999Despatch of a communication from the examining division (Time limit: M06)
22.05.2000Reply to a communication from the examining division
08.11.2000Despatch of communication of intention to grant (Approval: Yes)
19.03.2001Communication of intention to grant the patent
19.06.2001Fee for grant paid
19.06.2001Fee for publishing/printing paid
Opposition(s)13.06.2002No opposition filed within time limit [2002/36]
Fees paidRenewal fee
22.02.1996Renewal fee patent year 03
24.02.1997Renewal fee patent year 04
23.02.1998Renewal fee patent year 05
22.02.1999Renewal fee patent year 06
21.02.2000Renewal fee patent year 07
21.02.2001Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US4381292  (BIEBER CHARLES P, et al) [A] 1-28* claim 9 *
 [X]  - Belgian Journal of Zoology 121 (suppl.1), p13 [X] 1-4,6-28,31,32 * De La Parra et al.:Inhibition of T-cell activation by LO-CD2-a, a rat monoclonal antibody against the human CD2 glycoprotein * * & Abstract 16 of the second Belgian Congress of Zoology, Diepenbeek, Belgium, November 15-16, 1991 * * See Abstract 16 *
 [Y]  - C.CUNNINGHAM AND W.J.HARRIS, "Antibody engineering-how to be human", TIBTECH, CAMBRIDGE,GB, (199204), vol. 10 [Y] 5,29,30 * column L, paragraph 2 *
 [Y]  - L. RIECHMANN ET AL., "Reshaping human antibodies for therapy", NATURE., LONDON GB, (19880324), vol. 332, no. 6162, pages 323 - 327 [Y] 5,29,30 * the whole document *
Examination   - H. Xia et al., Rat monoclonal antibodies specific for human T lymphocytes in: "Rat hybridomas and rat monoclonal antibodies, (H. Bazin Editor) CRC Press Boca Raton USA 1990, pages 309-322
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.